• Lung Stem Cells Discovery in Mice May Benefit Cystic Fibrosis Treatment
  • CFF’s Therapeutics Development Arm Endorses Trial of PTI-428, Symdeko Combo
  • Enterprise Therapeutics Raises $41M to Advance Mucus-targeting Therapies for CF
  • When Invisible Illness Becomes Visible
  • Translate Bio Readies 1st Clinical Trial of MRT5005, Potential Treatment for All CF Patients
  • Autogenic Drainage Physiotherapy Can Improve Lung Respiratory Mechanisms, Study Shows
  • Orkambi’s Components Trigger Liver Enzyme That Decreases Its Ability to Fight CF, Study Finds
  • NIH Agency Pioneers Collaborative Research into Rare Diseases
  • Abnormal Glucose Levels Linked to Poorer Lung Function in Cystic Fibrosis Youth, Study Shows
  • Bacteria Can Pass Memory of Biofilm Formation to Descendants, Study Shows
  • What Is Victory? Sharing Our Reality.
  • CF Foundation Opposes Lastest Version of Right to Try Act as Still Posing Risks